Transcriptome changes during peanut oral immunotherapy and omalizumab
treatment
- Sofia Bjorkander,
- Simon Kebede Merid,
- David Brodin,
- Josef Brandstrom,
- Fredrik Fagerstrom-billai,
- Marieke van der Heiden,
- Jon Konradsen,
- Michael Kabesch
, - Cornelis Drunen,
- Korneliusz Golebski,
- Anke-Hilse Maitland - van der Zee,
- Uros Potocnik,
- Susanne Vijverberg,
- Anna Nopp,
- Caroline Nilsson,
- Erik Melén
Sofia Bjorkander
Karolinska Institute
Corresponding Author:sofia.bjorkander@ki.se
Author ProfileMarieke van der Heiden
University Medical Centre Groningen
Author ProfileAnke-Hilse Maitland - van der Zee
Amsterdam University Medical Centres
Author Profile30 Jun 2021Submitted to Pediatric Allergy and Immunology 07 Jul 2021Reviewer(s) Assigned
21 Jul 2021Review(s) Completed, Editorial Evaluation Pending
27 Jul 2021Editorial Decision: Revise Major
20 Sep 20211st Revision Received
21 Sep 2021Review(s) Completed, Editorial Evaluation Pending
21 Sep 2021Reviewer(s) Assigned
13 Oct 2021Editorial Decision: Accept
Jan 2022Published in Pediatric Allergy and Immunology volume 33 issue 1. 10.1111/pai.13682 
